Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide

被引：1
|
作者：
Hirayama, Y [1 ]
Koyama, R [1 ]
Nagai, T [1 ]
Ohta, H [1 ]
Kondo, A [1 ]
Ishikawa, K [1 ]
Ishitani, K [1 ]
Matsunaga, T [1 ]
Sakamaki, S [1 ]
Niitsu, Y [1 ]
机构：
[1] Hokkaido Prefectural Sapporo Kitano Hosp, Sapporo, Hokkaido, Japan
来源：
INTERNAL MEDICINE | 2001年 / 40卷 / 11期
关键词：
ATRA; skin erythema; neuralgia;
D O I：
10.2169/internalmedicine.40.1136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a patient with an initial relapse of acute promyelocytic leukemia (APL) who achieved a second complete remission (CR) after treatment with arsenic trioxide. The patient, a 66-year-old woman diagnosed as having relapsed APL, received arsenic trioxide intravenously at a dose of 10 mg/day. At day 36, the patient achieved a second CR. The side effects were slight neuralgia and mild skin erythematous changes, which improved following cessation of the drug. Although arsenic trioxide may be effective for relapsed APL, it should be used with caution because of various complications.
引用
收藏
页码：1136 / 1139
页数：4
相关论文
共 50 条
  • [31] Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia
    Shindo, Motohiro
    Ikuta, Katsuya
    Addo, Lynda
    Ito, Satoshi
    Fujiya, Mikihiro
    Torimoto, Yoshihiro
    Kohgo, Yutaka
    CASE REPORTS IN HEMATOLOGY, 2012, 2012
  • [32] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia
    Shigeno, K
    Nakamura, S
    Naito, K
    Yoshida, H
    Fujisawa, S
    Shinjo, K
    Fujita, Y
    Matsui, H
    Sahara, N
    Takeshita, A
    Ohno, R
    Ohnishi, K
    BLOOD, 2002, 100 (11) : 264B - 264B
  • [33] Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy
    Huang, SY
    Yang, CH
    Chen, YC
    LEUKEMIA & LYMPHOMA, 2000, 38 (3-4) : 283 - +
  • [34] United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    Soignet, SL
    Frankel, SR
    Douer, D
    Tallman, MS
    Kantarjian, H
    Calleja, E
    Stone, RM
    Kalaycio, M
    Scheinberg, DA
    Steinherz, P
    Sievers, EL
    Coutré, S
    Dahlberg, S
    Ellison, R
    Warrell, RP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 3852 - 3860
  • [35] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    倪建华
    陈国强
    沈志祥
    李秀松
    刘海卫
    黄燕婷
    方智雯
    陈赛娟
    王振义
    陈竺
    中华医学杂志(英文版), 1998, (12) : 51 - 54
  • [36] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    倪建华
    陈国强
    沈志祥
    李秀松
    刘海卫
    黄燕婷
    方智雯
    陈赛娟
    王振义
    陈竺
    ChineseMedicalJournal, 1998, (12)
  • [37] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    Ni, JH
    Chen, GQ
    Shen, ZX
    Li, XS
    Liu, HW
    Huang, YT
    Fang, ZW
    Chen, SJK
    Wang, ZY
    Chen, Z
    CHINESE MEDICAL JOURNAL, 1998, 111 (12) : 1107 - 1110
  • [38] Clinical usefulness of arsenic trioxide in the treatment of acute promyelocytic leukemia
    Lo Coco, F
    HAEMATOLOGICA, 2002, 87 (05) : 452 - 453
  • [39] Summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide
    Jin, H
    Li, XQ
    Li, HY
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 8, 2004, 8 : 543 - 547
  • [40] Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
    H. Agis
    A. Weltermann
    G. Mitterbauer
    R. Thalhammer
    M. Edelhäuser
    H. L. Seewann
    P. Valent
    K. Lechner
    C. Fonatsch
    K. Geissler
    Annals of Hematology, 1999, 78 : 329 - 332
12345